BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37253211)

  • 21. Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non-clear Cell Renal Cell Carcinoma Patients.
    Luzzago S; Palumbo C; Rosiello G; Knipper S; Pecoraro A; Mistretta FA; Tian Z; Musi G; Montanari E; Soulières D; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
    Eur Urol Focus; 2021 May; 7(3):598-607. PubMed ID: 32444303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
    Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
    J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies.
    Zaorsky NG; Lehrer EJ; Kothari G; Louie AV; Siva S
    Eur Urol Oncol; 2019 Sep; 2(5):515-523. PubMed ID: 31302061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation Therapy for Patients with Advanced Renal Cell Carcinoma.
    Miccio JA; Oladeru OT; Jun Ma S; Johung KL
    Urol Clin North Am; 2020 Aug; 47(3):399-411. PubMed ID: 32600541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach.
    Siva S; Kothari G; Muacevic A; Louie AV; Slotman BJ; Teh BS; Lo SS
    Nat Rev Urol; 2017 Sep; 14(9):549-563. PubMed ID: 28631740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy.
    Karam JA; Wood CG
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):753-64. PubMed ID: 21763966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of cytoreductive nephrectomy in renal cell carcinoma.
    Chiong E; Wood CG; Margulis V
    Future Oncol; 2009 Aug; 5(6):859-69. PubMed ID: 19663735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrating Surgery in the Multidisciplinary Care of Advanced Renal Cell Carcinoma.
    Ray S; Dason S; Singer EA
    Urol Clin North Am; 2023 May; 50(2):311-323. PubMed ID: 36948674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma.
    Miller JA; Balagamwala EH; Angelov L; Suh JH; Rini B; Garcia JA; Ahluwalia M; Chao ST
    J Neurosurg Spine; 2016 Dec; 25(6):766-774. PubMed ID: 27391397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma.
    Kroeze SGC; Fritz C; Schaule J; Siva S; Kahl KH; Sundahl N; Blanck O; Kaul D; Adebahr S; Verhoeff JJC; Skazikis G; Roeder F; Geier M; Eckert F; Guckenberger M
    BJU Int; 2021 Jun; 127(6):703-711. PubMed ID: 33113260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma.
    Franzese C; Franceschini D; Di Brina L; D'Agostino GR; Navarria P; Comito T; Mancosu P; Tomatis S; Scorsetti M
    J Urol; 2019 Jan; 201(1):70-76. PubMed ID: 30179619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastasis-directed stereotactic body radiotherapy for oligometastatic renal cell carcinoma: extent of tumor burden eradicated by radiotherapy.
    Liu Y; Long W; Zhang Z; Zhang Z; Mai L; Huang S; Han H; Zhou F; Dong P; He L
    World J Urol; 2021 Nov; 39(11):4183-4190. PubMed ID: 34043023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic Ablative Radiation (SAbR) for Oligometastatic RCC.
    All S; Garant A; Hannan R
    Semin Radiat Oncol; 2021 Jul; 31(3):227-234. PubMed ID: 34090649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic Radiotherapy in the Treatment of Paraneoplastic Vasculitis in Oligometastatic Renal Cell Carcinoma.
    Burgess L; Keenan M; Zhou AL; Lypka K; Hasimja Saraqini D; Yao J; Martin S; Morash C; Watterson J; Canil C; MacRae R
    Curr Oncol; 2021 May; 28(3):1744-1750. PubMed ID: 34066912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrating innovative therapeutic strategies into the management of renal cell carcinoma.
    Dutcher JP; Mourad WF; Ennis RD
    Oncology (Williston Park); 2012 Jun; 26(6):526-30, 532, 534. PubMed ID: 22870536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent.
    Buglione M; Jereczek-Fossa BA; Bonù ML; Franceschini D; Fodor A; Zanetti IB; Gerardi MA; Borghetti P; Tomasini D; Di Muzio NG; Oneta O; Scorsetti M; Franzese C; Romanelli P; Catalano G; Dell'Oca I; Beltramo G; Ivaldi GB; Laudati A; Magrini SM; Antognoni P;
    Lung Cancer; 2020 Mar; 141():1-8. PubMed ID: 31926440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Correa RJM; Louie AV; Zaorsky NG; Lehrer EJ; Ellis R; Ponsky L; Kaplan I; Mahadevan A; Chu W; Swaminath A; Hannan R; Onishi H; Teh BS; Muacevic A; Lo SS; Staehler M; Siva S
    Eur Urol Focus; 2019 Nov; 5(6):958-969. PubMed ID: 31248849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function.
    Senger C; Conti A; Kluge A; Pasemann D; Kufeld M; Acker G; Lukas M; Grün A; Kalinauskaite G; Budach V; Waiser J; Stromberger C
    BMC Urol; 2019 Oct; 19(1):96. PubMed ID: 31638979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimodal treatment of advanced renal cancer in 2017.
    Mennitto A; Verzoni E; Grassi P; Ratta R; Fucà G; Procopio G
    Expert Rev Clin Pharmacol; 2017 Dec; 10(12):1395-1402. PubMed ID: 28956645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Local Ablative Therapy in Patients with Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer.
    Kim C; Hoang CD; Kesarwala AH; Schrump DS; Guha U; Rajan A
    J Thorac Oncol; 2017 Feb; 12(2):179-193. PubMed ID: 27780780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.